A large cohort study may be necessary to assess the role of HMGB-1 and RAGE in the inflammatory response and oncogenesis in MPN, or elevated HMGB1 may be increased intracellularly and cannot be detected in the plasma. This evidence concerns the gene HMGB1 and myeloproliferative disorder.